ImmunityBio, Inc. (IBRX)
7.03
+0.11
(+1.59%)
USD |
NASDAQ |
Jan 22, 11:52
ImmunityBio Shareholders Equity (Quarterly): -524.32M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 77.40M |
| Aveanna Healthcare Holdings, Inc. | 9.184M |
| Corcept Therapeutics, Inc. | 631.90M |
| Cytokinetics, Inc. | -521.12M |
| Altimmune, Inc. | 185.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 518.99M |
| Total Liabilities (Quarterly) | 1.042B |
| Debt to Equity Ratio | -1.643 |
| Current Ratio | 5.767 |
| Net Debt Paydown Yield | 1.14% |